Skip to main content
Top
Published in: BMC Gastroenterology 1/2007

Open Access 01-12-2007 | Research article

Delayed diagnosis of coeliac disease increases cancer risk

Authors: Marco Silano, Umberto Volta, Anna Maria Mecchia, Mariarita Dessì, Rita Di Benedetto, Massimo De Vincenzi, the collaborating centers of the Italian registry of the complications of coeliac disease

Published in: BMC Gastroenterology | Issue 1/2007

Login to get access

Abstract

Background

The association between coeliac disease (CD) and neoplasms has been long established, but few data are available about the risk factors. The aim of this paper is to estimate the risk of developing a neoplasm among non diagnosed coeliac patients and to evaluate if this risk correlates with the age of patients at diagnosis of coeliac disease.

Methods

The study population consists of patients (n = 1968) diagnosed with CD at 20 Italian gastroenterology referral Centers between 1st January 1982 and 31st March 2005.

Results

The SIR for all cancers resulted to be 1.3; 95% CI = 1.0–1.7 p < 0.001. The specific SIRs for non Hodgkin lymphoma was 4.7; 95% CI = 2.9–7.3 p < 0.001, for the small bowel carcinoma 25; 95% CI = 8.5–51.4 p < 0.001, for non Hodgkin lymphoma 10; 95% CI = 2.7–25 p = 0.01, finally for the stomach carcinoma 3; 95% CI = 1.3–4.9 p < 0.08. The mean age at diagnosis of CD of patients that developed sooner or later a neoplasm was 47,6 ± 10.2 years versus 28.6 ± 18.2 years of patients who did not.

Conclusion

Coeliac patients have an increased risk of developing cancer in relation to the age of diagnosis of CD. This risk results higher for malignancies of the gastro-intestinal sites. An accurate screening for tumors should be performed in patients diagnosed with CD in adulthood and in advancing age.
Literature
1.
go back to reference Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001, 120: 636-51. 10.1053/gast.2001.22123.CrossRefPubMed Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001, 120: 636-51. 10.1053/gast.2001.22123.CrossRefPubMed
2.
go back to reference Volta U, Bellentani S, Bianchi FB, Brandi G, De Franceschi L, Miglioli L, Granito A, Balli F, Tiribelli C: High prevalence of celiac disease in Italian general population. Dig Dis Sci. 2001, 46: 1500-5. 10.1023/A:1010648122797.CrossRefPubMed Volta U, Bellentani S, Bianchi FB, Brandi G, De Franceschi L, Miglioli L, Granito A, Balli F, Tiribelli C: High prevalence of celiac disease in Italian general population. Dig Dis Sci. 2001, 46: 1500-5. 10.1023/A:1010648122797.CrossRefPubMed
3.
go back to reference West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, Reader R, Holmes GK, Khaw KT, et al: Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003, 52: 960-5. 10.1136/gut.52.7.960.CrossRefPubMedPubMedCentral West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, Reader R, Holmes GK, Khaw KT, et al: Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003, 52: 960-5. 10.1136/gut.52.7.960.CrossRefPubMedPubMedCentral
4.
go back to reference Fairly NH, Mackie FP: The clinical and biochemical syndrome in lymphoma and allied diseases involving the mesenteric lymph glannds. BMJ. 1937, 1: 375-380.CrossRef Fairly NH, Mackie FP: The clinical and biochemical syndrome in lymphoma and allied diseases involving the mesenteric lymph glannds. BMJ. 1937, 1: 375-380.CrossRef
6.
go back to reference Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR, Italian Working Group on Coeliac Disease and Non-Hodgkin's-Lymphoma: Risk of Non-Hodgkin lymphoma in celiac disease. JAMA. 2002, 287: 1413-1419. 10.1001/jama.287.11.1413.CrossRefPubMed Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR, Italian Working Group on Coeliac Disease and Non-Hodgkin's-Lymphoma: Risk of Non-Hodgkin lymphoma in celiac disease. JAMA. 2002, 287: 1413-1419. 10.1001/jama.287.11.1413.CrossRefPubMed
7.
go back to reference Green PH, Fleischauer AT, Bhagat G, et Goyal R, Jabri B, Neugut AI: Risk of malignancy in patients with celiac disease. Am J Med. 2003, 15: 191-195. 10.1016/S0002-9343(03)00302-4.CrossRef Green PH, Fleischauer AT, Bhagat G, et Goyal R, Jabri B, Neugut AI: Risk of malignancy in patients with celiac disease. Am J Med. 2003, 15: 191-195. 10.1016/S0002-9343(03)00302-4.CrossRef
11.
go back to reference Swinson CM, Slavin G, Coles EC, Booth CC: Coeliac disease and malignancy. Lancet. 1983, 15: 111-115. 10.1016/S0140-6736(83)91754-3.CrossRef Swinson CM, Slavin G, Coles EC, Booth CC: Coeliac disease and malignancy. Lancet. 1983, 15: 111-115. 10.1016/S0140-6736(83)91754-3.CrossRef
12.
go back to reference Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A: Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002, 123: 1428-1435. 10.1053/gast.2002.36585.CrossRefPubMed Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A: Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002, 123: 1428-1435. 10.1053/gast.2002.36585.CrossRefPubMed
13.
go back to reference Card TR, West J, Holmes GK: Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther. 2004, 20: 769-775. 10.1111/j.1365-2036.2004.02177.x.CrossRefPubMed Card TR, West J, Holmes GK: Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther. 2004, 20: 769-775. 10.1111/j.1365-2036.2004.02177.x.CrossRefPubMed
14.
go back to reference Peters U, Askling J, Gridley G, Ekbom A, Linet M: Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003, 163: 1566-1572. 10.1001/archinte.163.13.1566.CrossRefPubMed Peters U, Askling J, Gridley G, Ekbom A, Linet M: Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003, 163: 1566-1572. 10.1001/archinte.163.13.1566.CrossRefPubMed
15.
go back to reference Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Sategna Guidetti C, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabro A, Certo M, Club del Tenue Study Group: Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001, 358: 3563-61. 10.1016/S0140-6736(01)05554-4.CrossRef Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Sategna Guidetti C, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabro A, Certo M, Club del Tenue Study Group: Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001, 358: 3563-61. 10.1016/S0140-6736(01)05554-4.CrossRef
17.
go back to reference Egan LJ, Walsh SV, Stevens FM, Connoly CE, Egan EL, McCarthy CF: Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol. 1995, 21: 123-129. 10.1097/00004836-199509000-00012.CrossRefPubMed Egan LJ, Walsh SV, Stevens FM, Connoly CE, Egan EL, McCarthy CF: Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol. 1995, 21: 123-129. 10.1097/00004836-199509000-00012.CrossRefPubMed
18.
go back to reference Lewis HM, Renaula TL, Garioch JJ, Leonard JN, Fry JS, Collin P, Evans D, Fry L: Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996, 135: 363-367. 10.1046/j.1365-2133.1996.d01-1005.x.CrossRefPubMed Lewis HM, Renaula TL, Garioch JJ, Leonard JN, Fry JS, Collin P, Evans D, Fry L: Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996, 135: 363-367. 10.1046/j.1365-2133.1996.d01-1005.x.CrossRefPubMed
19.
go back to reference National Institutes of Health: Consensus Development Conference Statement on Celiac Disease. Gastroenterology. 2005, 128: S1-9. 10.1053/j.gastro.2005.02.007.CrossRef National Institutes of Health: Consensus Development Conference Statement on Celiac Disease. Gastroenterology. 2005, 128: S1-9. 10.1053/j.gastro.2005.02.007.CrossRef
21.
go back to reference Catassi C, Bearzi I, Holmes GK: Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005, 128: S79-86. 10.1053/j.gastro.2005.02.027.CrossRefPubMed Catassi C, Bearzi I, Holmes GK: Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005, 128: S79-86. 10.1053/j.gastro.2005.02.027.CrossRefPubMed
22.
go back to reference Freeman HJ: Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol. 2004, 38: 429-434. 10.1097/01.mcg.0000135363.12794.2b.CrossRefPubMed Freeman HJ: Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol. 2004, 38: 429-434. 10.1097/01.mcg.0000135363.12794.2b.CrossRefPubMed
23.
go back to reference Howdle PD, Jalal PK, Holmes GKT, Houlston RS: Primary small bowel malignancy in the U.K. and its association with coeliac disease. QJM. 2003, 96: 345-353. 10.1093/qjmed/hcg058.CrossRefPubMed Howdle PD, Jalal PK, Holmes GKT, Houlston RS: Primary small bowel malignancy in the U.K. and its association with coeliac disease. QJM. 2003, 96: 345-353. 10.1093/qjmed/hcg058.CrossRefPubMed
24.
go back to reference Bruno CJ, Batts KP, Ahlquist DA: Evidence against flat dysplasia as a regional field defect in small bowel adenocarcinoma associated with celiac sprue. Mayo Clin Proc. 1997, 72: 320-322.CrossRefPubMed Bruno CJ, Batts KP, Ahlquist DA: Evidence against flat dysplasia as a regional field defect in small bowel adenocarcinoma associated with celiac sprue. Mayo Clin Proc. 1997, 72: 320-322.CrossRefPubMed
25.
go back to reference West J, Logan RF, Smith CJ, Hubbard RB, Card TR: Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004, 329: 716-719. 10.1136/bmj.38169.486701.7C.CrossRefPubMedPubMedCentral West J, Logan RF, Smith CJ, Hubbard RB, Card TR: Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004, 329: 716-719. 10.1136/bmj.38169.486701.7C.CrossRefPubMedPubMedCentral
Metadata
Title
Delayed diagnosis of coeliac disease increases cancer risk
Authors
Marco Silano
Umberto Volta
Anna Maria Mecchia
Mariarita Dessì
Rita Di Benedetto
Massimo De Vincenzi
the collaborating centers of the Italian registry of the complications of coeliac disease
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2007
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-7-8

Other articles of this Issue 1/2007

BMC Gastroenterology 1/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.